APA (7th ed.) Citation

F, A., M, S., YA, A., M, A., A, A., M, A., . . . C, Z. (2023). Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer. Frontiers in oncology, 13, 1099696. https://doi.org/10.3389/fonc.2023.1099696

Chicago Style (17th ed.) Citation

F, Alshaebi, Safi M, Algabri YA, Al-Azab M, Aldanakh A, Alradhi M, Reem A, and Zhang C. "Interleukin-34 and Immune Checkpoint Inhibitors: Unified Weapons Against Cancer." Frontiers in Oncology 13 (2023): 1099696. https://doi.org/10.3389/fonc.2023.1099696.

MLA (9th ed.) Citation

F, Alshaebi, et al. "Interleukin-34 and Immune Checkpoint Inhibitors: Unified Weapons Against Cancer." Frontiers in Oncology, vol. 13, 2023, p. 1099696, https://doi.org/10.3389/fonc.2023.1099696.